trending Market Intelligence /marketintelligence/en/news-insights/trending/J32nvo6rfs3CNFexPOEu8g2 content esgSubNav
In This List

Centric Health Q2 loss narrows YOY

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection

Video

S&P Capital IQ Pro | Powered by Advanced Visualization

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage


Centric Health Q2 loss narrows YOY

Centric Health Corp. said its second-quarter normalized net income amounted to a loss of 1 Canadian cents per share, compared with a loss of 3 cents per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was a loss of C$1.7 million, compared with a loss of C$4.0 million in the year-earlier period.

The normalized profit margin rose to negative 3.7% from negative 9.7% in the year-earlier period.

Total revenue climbed on an annual basis to C$43.3 million from C$41.5 million, and total operating expenses increased from the prior-year period to C$42.3 million from C$41.8 million.

Reported net income totaled a loss of C$11.4 million, or a loss of 7 cents per share, compared to a loss of C$7.8 million, or a loss of 5 cents per share, in the year-earlier period.